Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
1999 • 3,605 citations
Classification of chronic viral hepatitis: a need for reassessment
1991 • 1,526 citations
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
2001 • 1,065 citations
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
1999 • 947 citations
Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein
2002 • 894 citations
Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
1999 • 685 citations
Etiopathogenesis of Nonalcoholic Steatohepatitis
2001 • 678 citations
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets
1997 • 649 citations
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
1997 • 628 citations
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
2000 • 590 citations
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis
2002 • 571 citations
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus
2002 • 467 citations
Hepatitis C Virus NS5A Colocalizes with the Core Protein on Lipid Droplets and Interacts with Apolipoproteins
2002 • 300 citations
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
2001 • 294 citations
Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection
2002 • 171 citations
Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates
1995 • 121 citations
Steatosis and intrahepatic hepatitis C virus in chronic hepatitis
1999 • 112 citations
Expression of liver steatosis in hepatitis C virus infection and pattern of response to α-interferon
2001 • 77 citations
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial
1998 • 60 citations
Noninvasive assessment of hepatic triglyceride content in humans with13C nuclear magnetic resonance spectroscopy
1996 • 36 citations
Molecular epidemiology of hepatitis C in Australia
1998 • 35 citations
Efficacy and tolerance of a 6‐month treatment course of daily interferon‐α2a for chronic hepatitis C with cirrhosis
1997 • 27 citations
Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy
1996 • 12 citations